Projected Earnings Date: 2024-08-05    (Delayed quote data   2025-06-30)
Last
 2.32
Change
 ⇑ +0.15   (+6.91%)
Volume
  205,651
Open
 2.19
High
 2.34
Low
 2.17
8EMA (Daily)
 2.26
40EMA (Daily)
 2.24
50EMA (Daily)
 2.24
STO (Daily)
 11.068
MACD Hist (Daily)
 -0.054
8EMA (Weekly)
 2.229
40EMA (Weekly)
 3.44
50EMA (Weekly)
 4.10
STO (Weekly)
 59.519
MACD Hist (Weekly)
 0.331
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
optionchance optionchance
Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com